Novel Regulatory Principles of Polycomb Repressive Complex 2
Posttranslational modifications of histone proteins have emerged as central regulators of gene expression. Through the factors that install, interpret, and erase them, histone marks control access to the genome, establishing chrom...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PRIME
Polycomb repressor interactions in relation to the mammalian...
2M€
Cerrado
SAF2013-48926-P
NUEVAS FUNCIONES DE LAS PROTEINAS POLYCOMB EN EL DESARROLLO,...
484K€
Cerrado
EUR2021-122005
RECLUTAMIENTO DE POLYCOMB DURANTE LA TRANSICION DE CICLO CEL...
100K€
Cerrado
CANCER EPIGENETICS
Comprehensive characterization of epigentic reprogramming in...
100K€
Cerrado
PREMORRIT
The Polycomb Repression Complex 2 PRC2 Mechanisms of recr...
100K€
Cerrado
BES-2017-081035
NUEVAS FUNCIONES DE LOS COMPLEJOS POLYCOMB EN REGULACION GEN...
93K€
Cerrado
Información proyecto PRCTOERC
Duración del proyecto: 85 meses
Fecha Inicio: 2015-04-22
Fecha Fin: 2022-05-31
Líder del proyecto
THE BABRAHAM INSTITUTE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
1M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Posttranslational modifications of histone proteins have emerged as central regulators of gene expression. Through the factors that install, interpret, and erase them, histone marks control access to the genome, establishing chromatin environments that either support or counteract transcription. The histone methyltransferase Polycomb repressive complex 2 (PRC2) is crucially involved in gene repression all throughout development and adulthood, and it is often misregulated in cancer. Despite significant advances in the field, key aspects of PRC2 function remain largely elusive. The overarching goal of this project is to enhance our understanding of how PRC2 is regulated and how it controls the expression of developmental genes in embryonic stem cells. To this end, my research team and I will analyse how PRC2 cooperates with other histone modifiers and chromatin organisers at enhancers to achieve poising of developmental genes (Aim 1). These studies will enable us to appreciate how the pivotal PRC2 module interfaces with other players in the complex chromatin regulatory system, contributing to a much-needed integrated view of chromatin regulation. We will further unravel how generation of the recently discovered asymmetric nucleosomes, in which the two copies of histone H3 are disparately modified (Voigt et al., Cell, 2012), is controlled by PRC2-intrinsic catalytic properties and through interactions with other chromatin modifiers (Aim 2). This will ultimately allow modulating asymmetry in vivo, providing unprecedented means to assess its impact on PRC2 function and chromatin structure. Lastly, I aim to re-evaluate the issue of PRC2 recruitment to its target loci by employing a systems biology-informed quantitative approach (Aim 3). Together, the aims of this ambitious project will significantly advance our understanding of PRC2 and its role in the establishment of chromatin states, which are crucial to embryonic stem cell physiology and deregulated in cancer.